SVF Endurance (Cayman) Ltd, 10% Owner at Vir Biotechnology, Inc. (VIR), sold 367,094 shares at $25.38 ($9.4M) on 2023-05-19, disclosed to the SEC on 2023-05-23.
Open-market sale of $9.4M VIR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.38 | 91,651 | $2.3M | 24.8% |
| 2 | $25.38 | 91,651 | $2.3M | 24.8% |
| 3 | $25.72 | 91,896 | $2.4M | 25.2% |
| 4 | $25.72 | 91,896 | $2.4M | 25.2% |
| Total | $25.55 avg | 367,094 | $9.4M | 100% |
| Filing → |
| VIR | SELL | 2025-10-30 | $319K | — | Filing → |
| VIR | SELL | 2025-10-22 | $2.7M | — | Filing → |
| VIR | SELL | 2025-10-17 | $359K | — | Filing → |